Globus Medical Inc - Ordinary Shares - Class A
GMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.99B
Close$
$242.19
227.5% upside
Current Fair Value
227.5% upsideUndervalued by 227.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.99 Billion |
|---|---|
| Enterprise Value | $9.63 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.98 |
| Beta | 0.96 |
| Outstanding Shares | 135,364,000 |
Return
| Return on Equity | 11.23% |
|---|---|
| Return on Assets | 9.76% |
| Return on Invested Capital | 13.01% |
Valuation & Multiples
| P/E Ratio | 18.66 |
|---|---|
| PEG | -73.82 |
| Price to Sales | 3.22 |
| Price to Book Ratio | 2.11 |
| Enterprise Value to Revenue | 3.06 |
| Enterprise Value to EBIT | 14.78 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$1.10
Average shareholder expectationRevenue Estimate
$782.88 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$1.20
Average shareholder expectationRevenue Estimate
$792.25 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1940▼ 29.69% |
|---|---|
| Total Calls | 419,100▲ 163.75% |
| Total Puts | 81,300▲ 4.23% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.81%▲ 7.92% |
|---|---|
| Total Invested | $9.53B▲ 1.05% |
| Investors Holding | 615▼ 4.00% |
ESG Score
No data
About Globus Medical Inc
CEO: David Demski